Skip to main content
. 2022 Sep 27;3(6):481–489. doi: 10.1158/2643-3230.BCD-22-0077

Figure 2.

Figure 2. The serological response to second and third vaccinations in individual patients with hematologic malignancies was analyzed for anti-S antibodies as described in the Methods. Individual lines represent each patient. Four types of responses were observed. Those patients who were seronegative prior to the third vaccination either remained persistent seronegative or seroconverted. Those patients who were seropositive prior to the third vaccination either had an increase in anti-S antibody levels (seroelevated) or had a small decrease in anti-S antibody levels (serodecreased). The red line in each graph represents the median anti-S antibody level.

The serological response to second and third vaccinations in individual patients with hematologic malignancies was analyzed for anti-S antibodies as described in the Methods. Individual lines represent each patient. Four types of responses were observed. Those patients who were sero­negative prior to the third vaccination either remained persistent seronegative or seroconverted. Those patients who were seropositive prior to the third vaccination either had an increase in anti-S antibody levels (seroelevated) or had a small decrease in anti-S antibody levels (serodecreased). The red line in each graph represents the median anti-S antibody level.